A judge has savaged Shine Lawyers over its failure to present a signed settlement agreement to the court a month after Johnson & Johnson Medical and unit Ethicon agreed to pay $300 million to settle two pelvic mesh class actions, ordering the firm to explain on the record what steps have been taken to finalise the settlement.
The judge overseeing a class action against US medical device maker Boston Scientific is considering appointing a contradictor to look over the $105 million settlement reached in the case, despite seeing no obvious obstacle to approving the deal.
A judge has paused a class action on behalf of 6,000 women allegedly injured by defective pelvic mesh devices pending determination of an application by Astora Health for a stay of the proceedings following its bankruptcy filing.
A judge has suggested that financial services giant AMP bring an application for summary dismissal of part of a class action over allegedly excessive insurance premiums, questioning the basis for the claims.
A woman allegedly injured by a defective pelvic mesh product has won her bid to bring a lawsuit against bankrupt Astora Women’s Health after she opted out of a class action, which promised her no more than $10,000 under a proposed settlement.
A judge has signed off on a $7.2 million penalty against Dixon Advisory after the company admitted to ASIC allegations that its advisors failed to act in its clients’ best interests by recommending they invest in a risky US-based real estate investment fund.
The High Court has taken up the appeal of a Whitsundays resort that was ordered to pay $430,738 to an employee whose roommate in staff accommodation urinated on him after a night of drinking.
Aussie Home Loans is facing a class action investigation for allegedly selling “essentially worthless” policies to homeowners.
Johnson & Johnson Medical and unit Ethicon have agreed to pay $300 million to settle two class actions brought by Shine Lawyers on behalf of Australian women implanted with pelvic mesh and tape devices.
A class action against cruise operator Carnival PLC over the 2020 COVID-19 outbreak aboard the Ruby Princess will ask the High Court to hear a challenge to a decision that found a class action waiver for foreign passengers was not unfair.